HCW Biologics Inc
HCWB4.170USD
+0.045+1.09%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
4.68MMarket Cap
LossP/E TTM
HCW Biologics Inc
4.170
+0.045+1.09%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total equity
Cash, cash equivalents and short-term investments
-72.88%1.11M
30.03%4.67M
-91.10%998.22K
-93.33%1.16M
-85.54%4.08M
-88.79%3.60M
-57.21%11.22M
-46.29%17.41M
-19.52%28.24M
-12.67%32.06M
-34.63%26.22M
541.75%32.41M
411.75%35.09M
--36.71M
--40.11M
--5.05M
--6.86M
- Cash and cash equivalents
-72.88%1.11M
30.03%4.67M
-91.10%998.22K
-84.41%1.16M
-77.79%4.08M
-83.90%3.60M
-57.21%11.22M
-51.69%7.45M
1.50%18.39M
90.32%22.33M
73.38%26.22M
205.30%15.42M
164.25%18.12M
--11.73M
--15.13M
--5.05M
--6.86M
-Short-term investments
----
----
----
----
----
-100.00%0.00
--0.00
-41.39%9.96M
-41.96%9.85M
-61.03%9.74M
-100.00%0.00
--16.99M
--16.97M
--24.98M
--24.99M
----
----
Receivables
-92.42%87.49K
-62.09%582.20K
-8.20%651.84K
-7.39%654.97K
356.57%1.15M
267.67%1.54M
99.71%710.08K
103.85%707.21K
-54.30%252.73K
214.06%417.69K
407.94%355.56K
593.87%346.93K
-57.46%553.01K
--133.00K
--70.00K
--50.00K
--1.30M
-Accounts and notes receivable
-90.32%87.49K
-62.09%582.20K
-8.20%651.84K
-7.39%654.97K
257.65%903.88K
267.67%1.54M
99.71%710.08K
103.85%707.21K
-54.30%252.73K
214.06%417.69K
407.94%355.56K
593.87%346.93K
-57.46%553.01K
--133.00K
--70.00K
--50.00K
--1.30M
-Loans receivable
----
----
----
----
--250.00K
----
----
----
----
----
----
----
----
----
----
----
----
Prepaid expenses
-67.29%256.29K
-68.52%328.18K
-79.56%356.16K
-70.15%404.92K
-30.84%783.42K
-25.27%1.04M
-9.35%1.74M
-2.93%1.36M
-43.94%1.13M
-36.50%1.39M
-3.46%1.92M
62.03%1.40M
157.95%2.02M
--2.20M
--1.99M
--862.50K
--783.32K
Other current assets
136.73%443.31K
-50.84%113.53K
-49.61%88.13K
-49.67%164.61K
-40.92%187.27K
17.81%230.92K
-15.07%174.88K
-30.42%327.06K
29.05%316.96K
-86.36%196.01K
-85.12%205.92K
-88.49%470.02K
-71.44%245.62K
--1.44M
--1.38M
--4.08M
--859.87K
Total current assets
-69.48%1.89M
-11.02%5.70M
-84.88%2.09M
-87.95%2.39M
-79.26%6.21M
-81.20%6.40M
-51.76%13.85M
-42.82%19.80M
-21.01%29.94M
-15.83%34.07M
-34.09%28.71M
244.69%34.63M
286.82%37.91M
--40.48M
--43.56M
--10.05M
--9.80M
Non-current assets
Net Fixed Assets
0.76%22.76M
12.01%22.91M
54.48%22.83M
80.67%22.81M
92.41%22.59M
89.30%20.45M
34.89%14.78M
1281.51%12.62M
1059.73%11.74M
865.48%10.80M
763.51%10.96M
-34.14%913.73K
-33.78%1.01M
--1.12M
--1.27M
--1.39M
--1.53M
Other non-current assets
0.00%28.48K
-49.63%28.48K
-99.47%28.48K
-99.48%28.48K
-88.75%28.48K
-83.07%56.54K
1185.75%5.39M
869.10%5.46M
-63.12%253.14K
-15.11%333.88K
--419.03K
--563.51K
--686.41K
--393.32K
----
----
----
Total non-current assets
0.71%24.39M
10.98%24.54M
12.38%24.46M
24.13%24.43M
78.16%24.22M
73.57%22.11M
-3.87%21.77M
54.02%19.68M
4.17%13.59M
-2.27%12.74M
76.27%22.65M
327.85%12.78M
317.12%13.05M
--13.03M
--12.85M
--2.99M
--3.13M
Total assets
-13.61%26.29M
6.04%30.24M
-25.44%26.56M
-32.07%26.82M
-30.11%30.43M
-39.09%28.51M
-30.64%35.62M
-16.72%39.48M
-14.56%43.53M
-12.53%46.81M
-8.96%51.35M
263.75%47.41M
294.15%50.96M
--53.51M
--56.41M
--13.03M
--12.93M
Liabilities
Current liabilities
Accrued expenses
-59.79%1.17M
-61.53%981.94K
-51.80%1.06M
174.60%6.34M
-9.11%2.92M
64.46%2.55M
209.52%2.19M
240.80%2.31M
532.98%3.21M
-26.03%1.55M
-59.70%708.25K
-78.64%677.65K
-50.42%507.38K
--2.10M
--1.76M
--3.17M
--1.02M
Short-term debt and lease liabilities
--6.23M
--6.31M
--6.34M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-Short-term debt
--6.23M
--6.31M
--6.34M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Total current liabilities
102.36%27.14M
238.71%29.63M
455.01%30.06M
411.67%23.22M
196.61%13.41M
195.88%8.75M
136.21%5.42M
296.48%4.54M
219.02%4.52M
27.35%2.96M
-4.23%2.29M
-72.55%1.14M
5.24%1.42M
--2.32M
--2.39M
--4.17M
--1.35M
Non-current liabilities
Long-term debt and lease liabilities
-6.88%7.71M
17.03%7.38M
2.05%6.46M
55.68%9.90M
29.42%8.27M
-1.87%6.30M
-2.65%6.33M
6360.03%6.36M
4480.12%6.39M
--6.42M
--6.50M
--98.45K
--139.60K
--0.00
--0.00
--0.00
--0.00
-Long-term debt
-6.88%7.71M
17.03%7.38M
2.05%6.46M
55.68%9.90M
29.57%8.27M
-1.65%6.30M
-1.79%6.33M
--6.36M
--6.39M
--6.41M
--6.45M
----
----
----
----
----
----
-Long-term lease liabilities
----
----
----
----
----
----
----
----
-94.64%7.48K
--14.28K
--56.68K
--98.45K
--139.60K
----
----
----
----
Other non-current liabilities
----
----
----
----
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
Total non-current liabilities
-6.88%7.71M
17.03%7.38M
2.05%6.46M
55.68%9.90M
29.42%8.27M
-1.87%6.30M
-2.65%6.33M
6360.03%6.36M
4480.12%6.39M
--6.42M
--6.50M
--98.45K
--139.60K
----
----
----
----
Total liabilities
60.68%34.85M
145.86%37.01M
210.88%36.53M
203.92%33.12M
98.68%21.69M
60.46%15.05M
33.55%11.75M
776.72%10.90M
601.06%10.92M
304.06%9.38M
267.42%8.80M
-70.19%1.24M
15.61%1.56M
--2.32M
--2.39M
--4.17M
--1.35M
Shareholders' equity
Common equity
8.59%94.19M
11.66%93.79M
4.17%87.21M
4.17%86.98M
4.22%86.74M
1.24%83.99M
1.26%83.72M
1.37%83.50M
1.38%83.23M
1.39%82.97M
1.47%82.67M
122941002.99%82.37M
139140923.73%82.09M
--81.83M
--81.48M
--67.00
--59.00
Retained earnings
-31.73%-102.75M
-42.57%-100.56M
-62.37%-97.18M
-69.87%-93.28M
-54.12%-78.00M
-54.89%-70.53M
-49.18%-59.85M
-51.67%-54.91M
-54.79%-50.61M
-48.64%-45.54M
-46.08%-40.12M
-55.79%-36.21M
-63.26%-32.69M
---30.64M
---27.46M
---23.24M
---20.03M
Capital reserves
8.59%94.19M
11.66%93.78M
4.17%87.21M
4.17%86.98M
4.22%86.74M
1.24%83.99M
1.26%83.72M
1.37%83.50M
1.38%83.22M
1.39%82.96M
1.47%82.67M
--82.37M
--82.09M
--81.83M
--81.47M
----
----
Total equity
-197.96%-8.56M
-150.29%-6.77M
-141.77%-9.97M
-122.04%-6.30M
-73.20%8.74M
-64.03%13.46M
-43.92%23.87M
-38.08%28.59M
-33.97%32.62M
-26.89%37.43M
-21.21%42.56M
420.82%46.17M
326.54%49.40M
--51.19M
--54.01M
--8.86M
--11.58M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
